Financials

  • Market Capitalization 5.92 M
  • Employee 2
  • Founded 2003
  • CEO N/A
  • Website www.pulmatrix.com
  • Headquarter Delaware, United States
  • FIGI BBG003TH2QL1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.05
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4924
PCSA
Processa Pharmaceuticals, Inc. - Common Stock
2.30 USD+11.65%+21.69%+5.02%+3.38%6.33 M USD
4932
CURX
Curanex Pharmaceuticals Inc - Common Stock
0.21 USD0.00%-16.00%-34.38%-94.47%5.96 M USD
4940
APVO
Aptevo Therapeutics Inc. - Common Stock
4.62 USD+11.33%+1.99%-0.43%-31.56%5.76 M USD
4943
ADIL
Adial Pharmaceuticals, Inc - Common Stock
2.65 USD-6.36%-7.67%-5.36%+597.37%5.68 M USD

Notizie